Nimbus Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Nimbus Therapeutics's estimated annual revenue is currently $18.9M per year.
- Nimbus Therapeutics's estimated revenue per employee is $155,000
- Nimbus Therapeutics's total funding is $637M.
Employee Data
- Nimbus Therapeutics has 122 Employees.
- Nimbus Therapeutics grew their employee count by 3% last year.
Nimbus Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Sr. VP and Head Chemistry | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | VP | Reveal Email/Phone |
4 | Chief Accounting Officer | Reveal Email/Phone |
5 | Chief Scientific Officer | Reveal Email/Phone |
6 | SVP Biology | Reveal Email/Phone |
7 | VP, CMC | Reveal Email/Phone |
8 | VP, Commercial Strategy | Reveal Email/Phone |
9 | VP, Head Intellectual Property | Reveal Email/Phone |
10 | VP, Clinical Operations | Reveal Email/Phone |
Nimbus Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Nimbus Therapeutics?
Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Massachusetts (USA). With its breakthrough computational chemistry platform, enabled through its privileged partnership with co-founder, Schrödinger, Inc., Nimbus is pioneering the application of computational chemistry to design treatments for substantial and underserved human diseases. The company?s focus on metabolic diseases, cancer and immune-inflammatory disorders reflects the mechanistic relationship between these disorders, and Nimbus? ability to rapidly tackle well validated targets as well as those that have proven intractable to the approaches taken by others in the pharmaceutical and biotechnology industry, resulting in medicines with high potency, selectivity and other desirable drug-like properties.
keywords:N/A
$637M
Total Funding
122
Number of Employees
$18.9M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Nimbus Therapeutics News
Entelos, Compugen, Genedata, Biognos Ab, Chemical Computing Group, Crown Bioscience, Rhenovia Pharma Limited, Leadscope, Schrodinger, Nimbus Therapeutics,...
Nimbus Therapeutics Strengthens Clinical Development Leadership Team. Published: Apr 13, 2022. April 13, 2022 11:00 UTC. CAMBRIDGE, Mass.
Nimbus Therapeutics is a clinical-stage company that designs and develops breakthrough medicines through its powerful and comprehensive...
Nimbus Therapeutics, a biotechnology company designing breakthrough medicines through structure-based drug discovery and development, today announced the closing of a $105 million private financing round. The round was led by BVF Partners L.P. (BVF), with participation from existing investors in ...
Nimbus Therapeutics, a Cambridge, Massachusetts-based biotechnology company, secured $65m in funding. Backers included Atlas Venture, SR One, Lilly Ventures, Bill Gates, Pfizer Venture Investments, Lightstone Ventures and Schrödinger. The company intends to use the funds to accelerate its pipe ...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 122 | 21% | N/A |
#2 | $25.8M | 123 | -8% | N/A |
#3 | $24.7M | 123 | 7% | N/A |
#4 | $19.1M | 123 | -5% | $207.5M |
#5 | $19.2M | 124 | 16% | $325M |